Michael Hallek to Busulfan
This is a "connection" page, showing publications Michael Hallek has written about Busulfan.
Connection Strength
0.050
-
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience. Haematologica. 2019 09; 104(9):1798-1803.
Score: 0.050